ApexQubit

Denis Farnosov

About ApexQubit

Founded:

2018

Funding:

€40,000

Raising:

€3,800,000

Team:

10

Business Stage:

MVP

About the Startup

ApexQubit is a biotechnology company that is harnessing a proprietary technology for the discovery of new medicines to treat patients with undruggable diseases.

What makes us unique?

The efficiency of drug discovery declines steadily while patients are still suffering from undruggable diseases. The solution is to unlock a new universe of potential RNA targets and drugs in convergence with AI for automation and quantum computing for unprecedented precision.

A potential drug candidate to increase the efficacy of immunotherapy treatment of breast cancer, lung cancer (NSCLC), and glioblastoma.

Go-to-market plan:

Direct sales to pharmaceutical companies. Potential first customers include Merck, AstraZeneca, Eli Lilly, J&J, Pfizer, Novartis.

Traction:

Lead drug candidate has successfully passed in vitro laboratory experiments

Management Team:

Dr Zhiyong Zhang, CSO, Platform – AI&Quantum
Dr Tom Wang, CSO, RNA Biology

Ask:

€3,800,000